COLLEEN DRISCOLL: Open Payments
NPI 1972988962 · BRUNSWICK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 41 payments from 12 companies in 2025. Trend: 2023 $153 · 2024 $497 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $360 |
| QOL Medical, LLC | 3 | $62 |
| Madrigal Pharmaceuticals | 2 | $59 |
| Ardelyx, Inc. | 2 | $40 |
| PFIZER INC. | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| GENZYME CORPORATION | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 2 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: RINVOQ, SKYRIZI, Sucraid, REZDIFFRA, IBSRELA, VELSIPITY, IQIRVO, XIFAXAN.
Industry payments across OH — which companies pay providers there.
